Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obesity
  Free Subscription

Articles published in
Metabolism
    September 2026
  1. JIANG S, Chen S, Wan M, Nie S, et al
    STAU1 fine-tunes adipose thermogenesis by regulating Ucp1 mRNA stability.
    Metabolism. 2026;182:156658.
    >> Share

  2. AI W, Pan Q, Shen Z, Yang W, et al
    Hepatic TGFbeta1 signaling impairs insulin sensitivity via inducing insulin receptor substrate 1 degradation.
    Metabolism. 2026;182:156654.
    >> Share

  3. VUJOVIC N, Koh HE, Heng SW, Panjwani P, et al
    Constant-routine protocol reveals an endogenous circadian rhythm in diet-induced thermogenesis with a peak in the biological morning.
    Metabolism. 2026;182:156655.
    >> Share

    July 2026
  4. TORRES-GRANADOS C, Morris PG, Ruiz-Cruz M, Pomares O, et al
    The endogenous ghrelin antagonist, LEAP2, accelerates puberty onset in conditions of early obesity.
    Metabolism. 2026;183:156695.
    >> Share

  5. VELASCO I, Frey JM, Baglaev V, Jafari T, et al
    Ablation of microglial estrogen receptor alpha predisposes male mice to diet-induced obesity.
    Metabolism. 2026 Jul 2:156689. doi: 10.1016/j.metabol.2026.156689.
    >> Share

    June 2026
  6. FERRARI D, Bonaventura I, Tenuta M, Pofi R, et al
    Rethinking hypercortisolism screening in obesity and diabetes: A systematic review and meta-analysis.
    Metabolism. 2026 Jun 14:156675. doi: 10.1016/j.metabol.2026.156675.
    >> Share

  7. DELLA GUARDIA L, Shin AC
    Adipose tissue catecholamine resistance: a metabolic safeguard that challenges weight control.
    Metabolism. 2026;179:156590.
    >> Share

    May 2026
  8. CORREA-BURROWS P, Burrows R, Kennedy BK, Gonzalez-Billault C, et al
    Obesity and biological aging across the life course: A geroscience framework for metabolic health.
    Metabolism. 2026;181:156634.
    >> Share

    April 2026
  9. MUZUROVIC E, Katsiki N, Volcansek S, Plescia F, et al
    Emerging incretin- and multi-agonist-based treatments - the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond.
    Metabolism. 2026;177:156494.
    >> Share

  10. PANUNZI S, Russo S, Pompa M, De Gaetano A, et al
    Personalizing bariatric metabolic surgery: Predictors of weight-loss success and risk of weight recurrence.
    Metabolism. 2026;177:156495.
    >> Share

  11. STEFANAKIS K, Gutierrez de Pineres V, Veeragandham P, Mantzoros CS, et al
    Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutide.
    Metabolism. 2026;177:156493.
    >> Share

    March 2026
  12. FU L, Ding R, Xu G, Hu J, et al
    Amycretin in obesity: Mechanisms, clinical efficacy, and future perspectives.
    Metabolism. 2026 Mar 16:156594. doi: 10.1016/j.metabol.2026.156594.
    >> Share

  13. LOPEZ M, Mantzoros CS
    Gallein targets AMPK in AgRP neurons: A new anti-obesity hypothalamic strategy?
    Metabolism. 2026 Mar 8:156588. doi: 10.1016/j.metabol.2026.156588.
    >> Share

    February 2026
  14. XUAN Y, Xiong X, Wang X, Wang Y, et al
    Targeting Gbetagamma subunits in hypothalamic AgRP neurons to treat obesity.
    Metabolism. 2026 Feb 19:156569. doi: 10.1016/j.metabol.2026.156569.
    >> Share

  15. SO J, Wann J, Kim K, Taleb S, et al
    Serum Response Factor (SRF) promotes actin cytoskeletal organization in adipocytes to support adaptive hypertrophic expansion and tissue remodeling during obesity in mice.
    Metabolism. 2026;178:156548.
    >> Share

  16. ZHU R, Guo J, Huttunen-Lenz M, Stratton G, et al
    Enduring improvements in hepatic insulin sensitivity predict sustained remission of prediabetes during a 3-year lifestyle intervention: results from the PREVIEW multinational diabetes prevention trial.
    Metabolism. 2026;178:156546.
    >> Share

  17. PEDERSEN L, Gliniak CM, Dale TM, Zhu Q, et al
    Induction of Yin Yang 1 (YY1) overexpression in mature adipocytes promotes dysfunctional adipose tissue and systemic insulin resistance in mice.
    Metabolism. 2026;175:156439.
    >> Share

  18. ZHANG J, Guan X, Kong M, Xia M, et al
    GLP-1RAs and tirzepatide may reduce heart failure risk in obese but not in non-obese patients with cardiovascular or renal disease: A systematic review and meta-analysis.
    Metabolism. 2026;175:156433.
    >> Share

    January 2026
  19. WANG S, Liu S, Zhang H, Sun L, et al
    Integrative functional genomics and fine-mapping identify regulatory mechanisms of multivariate obesity GWAS and its cardiometabolic implications.
    Metabolism. 2026 Jan 20:156509. doi: 10.1016/j.metabol.2026.156509.
    >> Share

  20. LEANZA G, Faraj M, Cannata F, Viola V, et al
    Bone inflammation in postmenopausal women with type 2 diabetes or obesity in relation to Wnt signaling and bone strength.
    Metabolism. 2026 Jan 8:156492. doi: 10.1016/j.metabol.2026.156492.
    >> Share

  21. GERLACH PA, Gadgaard S, Madsen JS, Lindquist P, et al
    Global glucagon-like peptide-2 receptor activation linked to increased obesity risk in the UK Biobank.
    Metabolism. 2026 Jan 8:156489. doi: 10.1016/j.metabol.2025.156489.
    >> Share

    December 2025
  22. KARAKASIS P, Vlachos K, Fragakis N, Mantzoros CS, et al
    Incretin-based therapy and atrial fibrillation risk in overweight or obesity.
    Metabolism. 2025 Dec 30:156491. doi: 10.1016/j.metabol.2025.156491.
    >> Share

  23. KARAKASIS P, Vlachos K, Antoniadis AP, Siontis KC, et al
    Effect of GLP-1 receptor agonists and co-agonists on atrial fibrillation risk in overweight or obesity: systematic review and meta-analysis of randomized controlled trials.
    Metabolism. 2025;175:156463.
    >> Share

  24. GIANNAKOGEORGOU A, Kahl S, Granata C, Heilmann G, et al
    Relationship of GDF15 with hepatic mitochondrial respiration is depending on the presence of fibrosis in obese individuals.
    Metabolism. 2025;173:156391.
    >> Share

  25. GUO DF, Luo Z, Olson A, Morgan DA, et al
    SerpinA3N in leptin-sensitive neurons is required for energy and glucose homeostasis and autonomic regulation.
    Metabolism. 2025;173:156387.
    >> Share

  26. YU L, Yuan J, Meng M, Pan H, et al
    Unravelling the obesity paradox in cancer: An umbrella review of protective associations and evidence credibility across 13 malignancies.
    Metabolism. 2025 Dec 1:156461. doi: 10.1016/j.metabol.2025.156461.
    >> Share

    November 2025
  27. DAI J, Zeng Z, Wang L, Yuan W, et al
    Obesity rewires CD8+ T cell iron metabolism in adipose tissue to fuel metabolic inflammation.
    Metabolism. 2025;175:156438.
    >> Share

    October 2025
  28. ASHLAW EF, Elfers CT, Chichura KS, Miranda IC, et al
    A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity.
    Metabolism. 2025 Oct 13:156414. doi: 10.1016/j.metabol.2025.156414.
    >> Share

    September 2025
  29. PHILIPPE MA, Fruchet B, Cagninacci L, Beaudoin L, et al
    BMAL2 controls adipose tissue inflammation and metabolic adaptation during obesity.
    Metabolism. 2025 Sep 20:156396. doi: 10.1016/j.metabol.2025.156396.
    >> Share

  30. DOS REIS ARAUJO T, da Silva Junior JA, Alves BL, Guimaraes DSPSF, et al
    Disruption of mitochondria-associated membranes contributes to the dysregulation of insulin secretion in undernutrition, obesity, and double burden of malnutrition.
    Metabolism. 2025 Sep 15:156393. doi: 10.1016/j.metabol.2025.156393.
    >> Share

  31. LIU J, Oliverio A, Godlewski G, Kocvarova R, et al
    Hepatic CB1 receptor signaling triggers G(i/o)alpha-mediated lipolysis in lean mice but G(s)alpha-mediated lipogenesis in obese mice.
    Metabolism. 2025;170:156308.
    >> Share

  32. CUTHBERTSON DJ, Kennedy OJ, Bilson J, Hydes TJ, et al
    Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomes.
    Metabolism. 2025;170:156306.
    >> Share

  33. BHATTACHARJEE P, Dvoracsko S, Pointeau O, Kundu B, et al
    Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders.
    Metabolism. 2025;170:156291.
    >> Share

    August 2025
  34. ZHANG XD, Zhong YS, Yan H, Jin LH, et al
    Chemical discovery of a novel MD2/ADAM17 dual-target inhibitor as a potential therapeutic candidate for saturated fatty acid-induced myocardial inflammatory injury.
    Metabolism. 2025;169:156298.
    >> Share

  35. LEE YH, Lee J, Jeong J, Park K, et al
    Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1.
    Metabolism. 2025;169:156266.
    >> Share

  36. MUND C, Sinha A, Aderhold A, Mateska I, et al
    A key role of polyamine metabolism in adipose tissue homeostasis that regulates obesity.
    Metabolism. 2025 Aug 1:156358. doi: 10.1016/j.metabol.2025.156358.
    >> Share

    July 2025
  37. EL KOUCHE S, Meyre D
    Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis.
    Metabolism. 2025 Jul 23:156353. doi: 10.1016/j.metabol.2025.156353.
    >> Share

  38. KASAHARA K, Ichikawa Y, Hironaka J, Shinozaki T, et al
    Time for a change? Threshold for obesity in contemporary Japanese population.
    Metabolism. 2025 Jul 15:156352. doi: 10.1016/j.metabol.2025.156352.
    >> Share

    June 2025
  39. KATSAROU A, Papadopoulos G, Moustakas II, Papadopetraki A, et al
    Exercise mitigates liver senescence but does not outmatch dietary restriction in obesity-related MASLD.
    Metabolism. 2025 Jun 10:156325. doi: 10.1016/j.metabol.2025.156325.
    >> Share

  40. HINDSO M, Lundsgaard A, Marinkovic B, Jensen MH, et al
    Fat absorption and metabolism after Roux-en-Y gastric bypass surgery.
    Metabolism. 2025;167:156189.
    >> Share

    May 2025
  41. GALAN A, Garcia-Garcia F
    Revisiting gender differences in obesity and type 2 diabetes: Response letter.
    Metabolism. 2025 May 29:156307. doi: 10.1016/j.metabol.2025.156307.
    >> Share

  42. SON YL, Hou J, Kato-Suzuki M, Okamatsu-Ogura Y, et al
    Corrigendum to "Eva1 deficiency prevents obesity-induced metabolic disorders by reducing visceral adipose dysfunction" [Metabolism 168 (2025) 156235].
    Metabolism. 2025;170:156299.
    >> Share

  43. ZHU H, Yi X, He M, Wu S, et al
    Exploring the interplay of genetic variants and environmental factors in childhood obesity: A systematic review and meta-analysis.
    Metabolism. 2025;170:156303.
    >> Share

    April 2025
  44. LENG S, Zhang X, Zhao R, Jiang N, et al
    Mechanical activation of adipose tissue macrophages mediated by Piezo1 protects against diet-induced obesity by regulating sympathetic activity.
    Metabolism. 2025 Apr 7:156262. doi: 10.1016/j.metabol.2025.156262.
    >> Share

  45. ZHONG Y, Wei J, Jiang R
    Revisiting gender differences in obesity and type 2 diabetes: Letter to the editor.
    Metabolism. 2025 Apr 3:156260. doi: 10.1016/j.metabol.2025.156260.
    >> Share

    March 2025
  46. MOLDOVAN RA, Hidalgo MR, Castane H, Jimenez-Franco A, et al
    Landscape of sex differences in obesity and type 2 diabetes in subcutaneous adipose tissue: a systematic review and meta-analysis of transcriptomics studies.
    Metabolism. 2025 Mar 27:156241. doi: 10.1016/j.metabol.2025.156241.
    >> Share

  47. RIBAS-LATRE A, Hoffmann A, Gebhardt C, Weiner J, et al
    The serine protease KLK7 promotes immune cell infiltration in visceral adipose tissue in obesity.
    Metabolism. 2025;168:156239.
    >> Share

  48. SON YL, Hou J, Kato-Suzuki M, Okamatsu-Ogura Y, et al
    Eva1 deficiency prevents obesity-induced metabolic disorders by reducing visceral adipose dysfunction.
    Metabolism. 2025 Mar 19:156235. doi: 10.1016/j.metabol.2025.156235.
    >> Share

  49. ZHANG T, Ren Z, Mao R, Yi W, et al
    LINC00278 and BRG1: A key regulatory axis in male obesity and preadipocyte adipogenesis.
    Metabolism. 2025 Mar 17:156194. doi: 10.1016/j.metabol.2025.156194.
    >> Share

  50. KARAKASIS P, Patoulias D, Fragakis N, Mantzoros CS, et al
    Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.
    Metabolism. 2025;164:156113.
    >> Share

  51. ZENG X, Wang Y, Farias K, Rappa A, et al
    NRH, a potent NAD(+) enhancer, improves glucose homeostasis and lipid metabolism in diet-induced obese mice through an active adenosine kinase pathway.
    Metabolism. 2025;164:156110.
    >> Share

    January 2025
  52. HU Y, Hai J, Ti Y, Kong B, et al
    Adipose ZFP36 protects against diet-induced obesity and insulin resistance.
    Metabolism. 2025;164:156131.
    >> Share

  53. HE Y, Zhang C, Wu S, Li K, et al
    Central NUCB2/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus.
    Metabolism. 2025;162:156046.
    >> Share

    December 2024
  54. MELA V, Martin-Reyes F, Oliva-Olivera W, Cantarero-Cuenca A, et al
    Serum miR-365b-5p/miR-222-5p as a potential diagnostic biomarker for long-term weight loss in patients with morbid obesity after bariatric surgery.
    Metabolism. 2024 Dec 30:156129. doi: 10.1016/j.metabol.2024.156129.
    >> Share

  55. PERAKAKIS N, Mantzoros CS
    Evidence from clinical studies of leptin: current and future clinical applications in humans.
    Metabolism. 2024;161:156053.
    >> Share

  56. STEFANAKIS K, Kokkorakis M, Mantzoros CS
    The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation.
    Metabolism. 2024;161:156057.
    >> Share

  57. MUNZBERG H, Heymsfield SB, Berthoud HR, Morrison CD, et al
    History and future of leptin: Discovery, regulation and signaling.
    Metabolism. 2024;161:156026.
    >> Share

    November 2024
  58. BUCHWALD LM, Neess D, Hansen D, Doktor TK, et al
    Body weight control via protein kinase CK2: diet-induced obesity counteracted by pharmacological targeting.
    Metabolism. 2024;162:156060.
    >> Share

  59. ZHANG H, Zhou XD, Shapiro MD, Lip GYH, et al
    Global burden of metabolic diseases, 1990-2021.
    Metabolism. 2024;160:155999.
    >> Share

    October 2024
  60. CONFORTO R, Rizzo V, Russo R, Mazza E, et al
    Advances in body composition and gender differences in susceptibility to frailty syndrome: Role of osteosarcopenic obesity.
    Metabolism. 2024 Oct 26:156052. doi: 10.1016/j.metabol.2024.156052.
    >> Share

  61. SERRANO J, Kondo S, Link GM, Brown IS, et al
    A partial loss-of-function variant (Ile191Val) of the TAS1R2 glucose receptor is associated with enhanced responses to exercise training in older adults with obesity: A translational study.
    Metabolism. 2024 Oct 9:156045. doi: 10.1016/j.metabol.2024.156045.
    >> Share

    September 2024
  62. XIE Z, Zheng G, Liang Z, Li M, et al
    Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.
    Metabolism. 2024 Sep 19:156038. doi: 10.1016/j.metabol.2024.156038.
    >> Share

  63. BAGHERI M, Tanriverdi K, Iafrati MD, Mosley JD, et al
    Characterization of the plasma metabolome and lipidome in response to sleeve gastrectomy and gastric bypass surgeries reveals molecular patterns of surgical weight loss.
    Metabolism. 2024;158:155955.
    >> Share

    August 2024
  64. LIM JH, Kim Y, Kim MY, Kim EN, et al
    Placental growth factor deficiency initiates obesity- and aging-associated metabolic syndrome.
    Metabolism. 2024 Aug 20:156002. doi: 10.1016/j.metabol.2024.156002.
    >> Share

    July 2024
  65. RICHTER MM, Kemp IM, Heeboll S, Winther-Sorensen M, et al
    Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
    Metabolism. 2024;156:155915.
    >> Share

    June 2024
  66. JOLLET M, Tramontana F, Jiang LQ, Borg ML, et al
    Diacylglycerol kinase delta overexpression improves glucose clearance and protects against the development of obesity.
    Metabolism. 2024 Jun 4:155939. doi: 10.1016/j.metabol.2024.155939.
    >> Share

    May 2024
  67. HUTTASCH M, Roden M, Kahl S
    Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
    Metabolism. 2024 May 21:155937. doi: 10.1016/j.metabol.2024.155937.
    >> Share

  68. AVENDANO MS, Perdices-Lopez C, Guerrero-Ruiz Y, Ruiz-Pino F, et al
    The evolutionary conserved miR-137/325 tandem mediates obesity-induced hypogonadism and metabolic comorbidities by repressing hypothalamic kisspeptin.
    Metabolism. 2024 May 8:155932. doi: 10.1016/j.metabol.2024.155932.
    >> Share

  69. NEDELCUT S, Axer S, Olbers T
    The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review.
    Metabolism. 2024;154:155799.
    >> Share

    April 2024
  70. ZELJKOVIC A, Vekic J, Stefanovic A
    Obesity and dyslipidemia in early life: Impact on cardiometabolic risk.
    Metabolism. 2024;156:155919.
    >> Share

  71. AWAZAWA M, Matsushita M, Nomura I, Kobayashi N, et al
    Imeglimin improves systemic metabolism by targeting brown adipose tissue and gut microbiota in obese model mice.
    Metabolism. 2024;153:155796.
    >> Share

  72. ROSENDO-SILVA D, Gomes PB, Rodrigues T, Viana S, et al
    Clinical and molecular profiling of human visceral adipose tissue reveals impairment of vascular architecture and remodeling as an early hallmark of dysfunction.
    Metabolism. 2024;153:155788.
    >> Share

    March 2024
  73. PENDERGRAST LA, Ashcroft SP, Ehrlich AM, Treebak JT, et al
    Metabolic plasticity and obesity-associated changes in diurnal postexercise metabolism in mice.
    Metabolism. 2024 Mar 11:155834. doi: 10.1016/j.metabol.2024.155834.
    >> Share

  74. MENG M, Cao Y, Qiu J, Shan G, et al
    Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner.
    Metabolism. 2024;152:155784.
    >> Share

  75. KOKKINOS A, Tsilingiris D, Simati S, Stefanakis K, et al
    Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study.
    Metabolism. 2024;152:155773.
    >> Share

  76. REGMI P, Young M, Minigo G, Milic N, et al
    Photoperiod and metabolic health: evidence, mechanism, and implications.
    Metabolism. 2024;152:155770.
    >> Share

  77. LAVILLE M, Robert M, Segrestin B
    Barriers to metabolic surgery and how to address them.
    Metabolism. 2024;152:155764.
    >> Share

    February 2024
  78. RACHELLE H, Malak G, Houry P, Marc H, et al
    Mortality risk in patients with obesity and COVID-19 infection: a systematic review and meta-analysis.
    Metabolism. 2024 Feb 13:155812. doi: 10.1016/j.metabol.2024.155812.
    >> Share

  79. SARABHAI T, Kahl S, Gancheva S, Mastrototaro L, et al
    Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease.
    Metabolism. 2024;151:155762.
    >> Share

  80. SAMARASINGHE SNS, Woods C, Miras AD
    Bariatric Surgery in Women with Polycystic Ovary Syndrome.
    Metabolism. 2024;151:155745.
    >> Share

  81. TSILINGIRIS D, Kokkinos A
    Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond.
    Metabolism. 2024;151:155741.
    >> Share

  82. MURPHY E, Finucane FM
    Addressing uncertainty about the role of structured lifestyle modification for metabolic surgery patients.
    Metabolism. 2024;151:155739.
    >> Share

  83. BAUZA-THORBRUGGE M, Vujicic M, Chanclon B, Palsdottir V, et al
    Adiponectin stimulates Sca1(+)CD34(-)-adipocyte precursor cells associated with hyperplastic expansion and beiging of brown and white adipose tissue.
    Metabolism. 2024;151:155716.
    >> Share

    January 2024
  84. FUKUSHIMA T, Maetani T, Chubachi S, Tanabe N, et al
    Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity.
    Metabolism. 2024;150:155715.
    >> Share

  85. ZIQUBU K, Dludla PV, Mabhida SE, Jack BU, et al
    Brown adipose tissue-derived metabolites and their role in regulating metabolism.
    Metabolism. 2024;150:155709.
    >> Share

    November 2023
  86. ALABDULJABBAR K, le Roux CW
    Pharmacotherapy before and after bariatric surgery.
    Metabolism. 2023;148:155692.
    >> Share

    October 2023
  87. KATSAROU A, Kouvari M, Hill MA, Mantzoros CS, et al
    Metabolically unhealthy obesity, sarcopenia and their interactions in obesity pathophysiology and therapeutics: Room for improvement in pharmacotherapy.
    Metabolism. 2023 Oct 27:155714. doi: 10.1016/j.metabol.2023.155714.
    >> Share

  88. STEINBACH E, Masi D, Ribeiro A, Serradas P, et al
    Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation.
    Metabolism. 2023 Oct 24:155712. doi: 10.1016/j.metabol.2023.155712.
    >> Share

  89. KARAKASIS P, Patoulias D, Pamporis K, Stachteas P, et al
    Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials.
    Metabolism. 2023 Oct 16:155710. doi: 10.1016/j.metabol.2023.155710.
    >> Share

  90. TSUKAMOTO S, Suzuki T, Wakui H, Uehara T, et al
    Angiotensin II type 1 receptor-associated protein in immune cells: a possible key factor in the pathogenesis of visceral obesity.
    Metabolism. 2023;149:155706.
    >> Share

  91. ULLAH R, Shen Y, Zhou YD, Fu J, et al
    Perinatal metabolic inflammation in the hypothalamus impairs the development of homeostatic feeding circuitry.
    Metabolism. 2023;147:155677.
    >> Share

    September 2023
  92. KOKKORAKIS M, Katsarou A, Katsiki N, Mantzoros CS, et al
    Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery.
    Metabolism. 2023;148:155689.
    >> Share

  93. CHEN W, Cui W, Wu J, Zheng W, et al
    Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion.
    Metabolism. 2023;146:155641.
    >> Share

    August 2023
  94. POLYZOS SA, Vachliotis ID, Mantzoros CS
    Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
    Metabolism. 2023 Aug 4:155676. doi: 10.1016/j.metabol.2023.155676.
    >> Share

  95. HOFFMANN A, Meir AY, Hagemann T, Czechowski P, et al
    A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial.
    Metabolism. 2023;145:155594.
    >> Share

  96. PARK SH, Helsley RN, Fadhul T, Willoughby JLS, et al
    Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD.
    Metabolism. 2023;145:155591.
    >> Share

    July 2023
  97. FERNANDEZ-SAEZ EM, Losarcos M, Becerril S, Valenti V, et al
    Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
    Metabolism. 2023 Jul 28:155663. doi: 10.1016/j.metabol.2023.155663.
    >> Share

  98. MUTURI HT, Ghadieh HE, Abdolahipour R, Stankus HL, et al
    Loss of CEACAM1 in endothelial cells causes hepatic fibrosis.
    Metabolism. 2023;144:155562.
    >> Share

    June 2023
  99. KOSCHKER AC, Warrings B, Morbach C, Seyfried F, et al
    Effect of bariatric surgery on cardio-psycho-metabolic outcomes in severe obesity: A randomized controlled trial.
    Metabolism. 2023 Jun 30:155655. doi: 10.1016/j.metabol.2023.155655.
    >> Share

  100. JUNG EJ, Sung KW, Bae TH, Kim HY, et al
    The N-degron pathway mediates lipophagy: The chemical modulation of lipophagy in obesity and NAFLD.
    Metabolism. 2023 Jun 27:155644. doi: 10.1016/j.metabol.2023.155644.
    >> Share

  101. AXELROD CL, Dantas WS, Kirwan JP
    Sarcopenic obesity: emerging mechanisms and therapeutic potential.
    Metabolism. 2023 Jun 26:155639. doi: 10.1016/j.metabol.2023.155639.
    >> Share

  102. WEI F, Gu Y, He L, Kapoor A, et al
    HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation.
    Metabolism. 2023;145:155631.
    >> Share

  103. BOUTARI C, Hill MA, Procaccini C, Matarese G, et al
    The key role of inflammation in the pathogenesis and management of obesity and CVD.
    Metabolism. 2023 Jun 9:155627. doi: 10.1016/j.metabol.2023.155627.
    >> Share

  104. OH J, Park C, Kim S, Kim M, et al
    High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity.
    Metabolism. 2023 Jun 9:155629. doi: 10.1016/j.metabol.2023.155629.
    >> Share

  105. DE OLIVEIRA MC, Silveira ALM, de Oliveira ACC, Lana JP, et al
    Eosinophils protect from metabolic alterations triggered by obesity.
    Metabolism. 2023 Jun 7:155613. doi: 10.1016/j.metabol.2023.155613.
    >> Share

  106. LIU B, Zhong Y, Huang D, Yang L, et al
    LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis.
    Metabolism. 2023 Jun 3:155609. doi: 10.1016/j.metabol.2023.155609.
    >> Share

  107. WANG H, Xiong Q, He G, Tang J, et al
    Hepatic IDH2 regulates glycolysis and gluconeogenesis.
    Metabolism. 2023;143:155559.
    >> Share

  108. BARAZZONI R, Cederholm T, Zanetti M, Gortan Cappellari G, et al
    Defining and diagnosing sarcopenia: Is the glass now half full?
    Metabolism. 2023;143:155558.
    >> Share

  109. BRETHVAD AO, Zakariassen HL, Holt J, Lundgren JR, et al
    Increased meal-induced neurotensin response predicts successful maintenance of weight loss - Data from a randomized controlled trial.
    Metabolism. 2023;143:155534.
    >> Share

    May 2023
  110. CAPPELLARI GG, Semolic A, Zanetti M, Vinci P, et al
    Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.
    Metabolism. 2023 May 26:155595. doi: 10.1016/j.metabol.2023.155595.
    >> Share

  111. JAVAID HMA, Ko E, Joo EJ, Kwon SH, et al
    TNFalpha-induced NLRP3 inflammasome mediates adipocyte dysfunction and activates macrophages through adipocyte-derived lipocalin 2.
    Metabolism. 2023;142:155527.
    >> Share

    April 2023
  112. PARK MJ, Choi KM
    Interplay of skeletal muscle and adipose tissue: sarcopenic obesity.
    Metabolism. 2023 Apr 29:155577. doi: 10.1016/j.metabol.2023.155577.
    >> Share

  113. GUO X, Hu J, He G, Chen J, et al
    Loss of APOO (MIC26) aggravates obesity-related whitening of brown adipose tissue via PPARalpha-mediated functional interplay between mitochondria and peroxisomes.
    Metabolism. 2023 Apr 21:155564. doi: 10.1016/j.metabol.2023.155564.
    >> Share

  114. CHONG B, Kong G, Shankar K, Chew HSJ, et al
    The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000-2019.
    Metabolism. 2023;141:155402.
    >> Share

  115. REBELOS E, Mari A, Oikonen V, Iida H, et al
    Evaluation of renal glucose uptake with [(18)F]FDG-PET: Methodological advancements and metabolic outcomes.
    Metabolism. 2023;141:155382.
    >> Share

    March 2023
  116. PAPADOPOULOS G, Legaki AI, Georgila K, Vorkas P, et al
    Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Metabolism. 2023 Mar 28:155552. doi: 10.1016/j.metabol.2023.155552.
    >> Share

  117. BIANZANO S, Henrich A, Herich L, Kalsch B, et al
    Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies.
    Metabolism. 2023 Mar 21:155550. doi: 10.1016/j.metabol.2023.155550.
    >> Share

  118. XU H, Yu W, Sun M, Bi Y, et al
    Syntaxin17 contributes to obesity cardiomyopathy through promoting mitochondrial Ca(2+) overload in a Parkin-MCUb-dependent manner.
    Metabolism. 2023 Mar 20:155551. doi: 10.1016/j.metabol.2023.155551.
    >> Share

  119. LUO X, Li Z, Chen L, Zhang X, et al
    Monocarboxylate transporter 1 in the liver modulates high-fat diet-induced obesity and hepatic steatosis in mice.
    Metabolism. 2023 Mar 16:155537. doi: 10.1016/j.metabol.2023.155537.
    >> Share

  120. MARLENE C, Christos MS
    Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy.
    Metabolism. 2023 Mar 2:155531. doi: 10.1016/j.metabol.2023.155531.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016